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Rethinking surgical care in conﬂ  ict
The provision of surgical assistance in conﬂ  ict is often 
associated with care for victims of violence. Images 
of the war wounded from bullets, bomb-blasts, and 
other violent assaults often feature prominently in the 
mass media. The discipline has been guided by military 
surgeons from the developed world who aim to develop 
approaches that use the latest surgical technologies in 
war zones.
1,2 However, in many conﬂ  icts, the bulk of 
surgical care is provided by non-military actors, including 
humanitarian organisations, who work with more 
limited resources.
3
Injury during conﬂ   ict contributes to substantial 
mortality, but major causes of excess mortality are often 
secondary: cholera, measles, and malnutrition are all 
exacerbated by mass population-displacements and 
overcrowded conditions for refugees.
4,5 Similarly, surgical 
needs in conﬂ  ict extend well beyond trauma: mortality 
from infection, poor nutrition, obstetric emergencies, 
and accidental injuries are all amenable to surgical 
intervention. A recent study from the Democratic 
Republic of Congo found that mortality from obstetric 
emergencies and accidental injury in conﬂ  ict was four 
times higher than that from violence.
5 In general, 
maternal and child mortality is higher in conﬂ  ict-aﬀ  ected 
and post-conﬂ   ict countries than in least-developed 
countries not directly aﬀ  ected by conﬂ  ict.
6
Surgical projects in conﬂ   icts rarely collect reliable 
statistics, but operational data suggests that civilian 
surgical needs are predominantly not related to combat. 
A retrospective review of surgical services of Médecins 
Sans Frontières in six conﬂ  ict settings found that only 
22% (1050) of 4630 surgical interventions were due 
to violent injury. Violence represented less than half of 
all surgical interventions in conﬂ  ict-aﬀ   ected areas in 
Pakistan (5%), South Sudan (21%), Chad (36%), and 
Somalia (41%). At almost all sites, obstetric emergencies 
vastly outnumbered the war-wounded, accounting for 
almost a third (30%) of all interventions, while accidental 
injury and tropical infections accounted for another third.
The fact that war-wounded often represent a minority 
of surgical needs is not suﬃ   ciently appreciated. A seven-
country review of health services for displaced populations 
found that not a single camp had an operating theatre 
that could provide life-saving surgery, such as caesarean 
section or bowel-rupture repair.
7 Other likely needs include 
an increase in complications of untreated infectious 
diseases, such as bowel perforation from typhoid fever 
and soft-tissue abscesses. Limiting surgical humanitarian 
assistance to the war-wounded will lead to partial needs-
assessments, and inadequate programme-planning and 
provision of supplies and human resources.
Part of the problem is a lack of reliable data on the 
surgical burden of disease in conﬂ  ict settings. No large 
population-based surveys have been published, and the 
few programme data that exist tend to reﬂ  ect availability 
of services rather than population needs. Without reliable 
survey data, we cannot know whether an increased 
caseload reﬂ  ects an increased disease burden related to 
the conﬂ  ict (more road-traﬃ   c accidents as people ﬂ  ee 
conﬂ  ict) or an underlying need that can no longer be met 
due to destruction of and limited access to health services.
The bias towards violence-related surgery is reﬂ  ected 
in the research ﬁ  eld, which has largely focused on the 
specialised surgical care of trauma.
8 In view of the dire 
shortage of surgeons in resource-limited settings, more 
emphasis should be placed on operational research to 
support the provision of essential surgical care by general 
doctors or non-physician clinicians, particularly because 
most essential surgical procedures required in conﬂ  ict-
aﬀ  ected zones are relatively simple interventions.
9
Whereas the emergency public health response to 
infec  tious diseases and malnutrition during conﬂ  ict  is 
well developed,
7 humanitarian practice-guidelines take 
a narrow view of surgical needs. The Sphere Project, an 
inter agency  eﬀ  ort dedicated to establishing minimum 
standards of humanitarian assistance for disaster 
response, limits its guidance for surgical programming 
to trauma and obstetric care.
10 These guidelines are 
under review, which presents an opportunity to more 
comprehensively address surgical needs in conﬂ  ict and 
postconﬂ  ict settings.
Services to support general surgery in conﬂ  ict settings 
are lacking mainly because most conﬂ  icts occur in least-
developed countries where surgical capacity is severely 
limited: the poorest third of countries beneﬁ  t from only 
3·5% of global surgical interventions.
11 With a growing 
appreciation of the substantial burden of surgical 
diseases across the developing world,
12 the relevance of 
the traditional models of surgical assistance for civilians 
in conﬂ  ict merits reconsideration.
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Ticagrelor in ACS: redeﬁ  ning a new standard of care?
Tremendous progress has been achieved over the past 
decade in the treatment of acute coronary syndromes 
(ST-segment elevation myocardial infarction [STEMI], 
non-STEMI [NSTEMI], and unstable angina). In STEMI, 
primary percutaneous coronary intervention compared 
with ﬁ  brinolytic therapy reduces mortality, reinfarction, 
stroke, infarct size, and recurrent ischaemia.
1 In 
moderate-risk and high-risk patients with NSTEMI, early 
angiography followed by revascularisation with either 
percutaneous coronary intervention or coronary artery 
bypass graft surgery compared with a more conservative 
approach reduces the rates of death or myocardial 
infarction, recurrent ischaemia, and rehospitalisation.
2,3 
Drug-eluting stents have been shown to be safe in acute 
coronary syndromes, and, compared with bare-metal 
stents, reduce clinical and angiographic restenosis,
4 
further improving quality of life. With expeditious 
revascularisation recognised as the cornerstone of the 
treatment of acute coronary syndromes, selecting the 
optimum pharmacotherapeutic regimen to support the 
invasive approach becomes imperative. Because platelet 
activation is intense in acute coronary syndromes, 
percutaneous coronary intervention, and coronary 
artery bypass graft surgery, it is not surprising that the 
thienopyridine clopidogrel, which inhibits ADP-induced 
platelet activation, when added to aspirin further 
suppresses ischaemic complications in acute coronary 
syndromes.
5,6 Prasugrel, which is more potent and rapid-
acting than clopidogrel, is even better at preventing 
myocardial infarction and stent thrombosis in 
patients with an acute coronary syndrome undergoing 
percutaneous coronary intervention.
7 However, pro-
portional to their potency, these oral agents increase 
haemorrhagic complications, the occurrence of which 
has been strongly linked to subsequent mortality.
8,9 
As a result, neither thienopyridine has been shown to 
improve survival in acute coronary syndromes.
Enter ticagrelor, an oral non-thienopyridine cyclo-pentyl-
triazolo-pyrimidine ADP-receptor (P2Y12 ant  agonist, 
which like prasugrel is more potent and rapid-acting than 
clopidogrel. In the PLATO trial, this agent was compared 
with clopidogrel in more than 18  500 patients with 
acute coronary syndromes.
10 In The Lancet, today, the 
PLATO investigators
11 now report the detailed outcomes 
in around 13 000 patients (72·0% of all those enrolled) 
managed with an urgent early invasive approach. 
Like prasugrel, ticagrelor compared with clopidogrel 
signiﬁ  cantly reduced rates of myocardial infarction and 
stent thrombosis, accompanied by an increase in major 
bleeding that was unrelated to coronary artery bypass 
graft surgery. However, that is where the comparison 
ends. In TRITON, prasugrel increased bleeding that was 
related to coronary artery bypass graft surgery, all-cause 
bleeding, and transfusions, as well as life-threatening and 
fatal bleeding which largely oﬀ  set its expected beneﬁ  ts 
from prevention of myocardial infarction and stent 
thrombosis. As a result, total mortality at 15 months was 
not signiﬁ  cantly diﬀ  erent with prasugrel and clopidogrel 
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